Trials / Unknown
UnknownNCT04616820
Endocan Blood Level in Pulmonary Circulation
Venous Pulmonary Compared to Venous Systemic Blood Level of Endocan During On-pump Cardiac Surgery
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Endocan is a proteoglycan produced by the vascular endothelium. Animal studies suggested that the synthesis mainly happen in the pulmonary circulation, but this hypothesis has never been confirmed in humans.
Detailed description
The investigators will measure endocan levels in both pulmonary and systemic venous blood in patients undergoing on pump cardiac surgery. The main objective is to quantify the difference of endocan blood level between the pulmonary and the systemic circulation.
Conditions
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
- First posted
- 2020-11-05
- Last updated
- 2021-02-05
Source: ClinicalTrials.gov record NCT04616820. Inclusion in this directory is not an endorsement.